Allopurinol

  • 1 lab in 1 country
  • 1 finding against
  • Funders: National Science and Technology Council and 2 more
  • Humans2

Outcomes

1

Frailty

no changein humans1

1 study
  1. Allopurinol has no effect on frailty in humans.

    Humansworsening frailty in nephrology patientsmedian follow-up of 3.0 yearsn = 19,389

    Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients

    International journal of medical sciences4 Aug 2026

Associations

1

Frailty

downin humans1HR 0.65

1 study
  1. Allopurinol lowers the risk of frailty in humans (HR 0.65, 95% CI 0.46-0.93).

    Humansin nephrology patients versus non-usersmedian follow-up of 3.0 yearsn = 19,389

    Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients

    International journal of medical sciences4 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 0Oct 2026: 02 in 12 months